MS Trial Alert: Investigators Recruiting People with MS-Related Muscle Spasticity for Study of Extended-Release Baclofen
January 17, 2017
January 17, 2017
NEW YORK, Jan. 17 -- The National Multiple Sclerosis Society issued the following news:
Summary: Investigators nationwide are recruiting 135 people with any form of multiple sclerosis for a research study to determine the effectiveness of extended-release baclofen capsules (a high dose, a low dose, or inactive placebo) in relieving muscle spasticity related to MS. The study is sponsored by Sun Pharma Advanced Research Company Limited.
Rationale: Spasticity refers to . . .
Summary: Investigators nationwide are recruiting 135 people with any form of multiple sclerosis for a research study to determine the effectiveness of extended-release baclofen capsules (a high dose, a low dose, or inactive placebo) in relieving muscle spasticity related to MS. The study is sponsored by Sun Pharma Advanced Research Company Limited.
Rationale: Spasticity refers to . . .